FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123223887> ?p ?o ?g. }

• W2123223887 endingPage "48" @default.
• W2123223887 startingPage "48" @default.
• W2123223887 abstract "Ambigous results exist on fetuin-A as marker for vascular disease in type 2 diabetes. This study aims to define the role of fetuin-A as marker for micro- and macrovascular disease in a high risk population of patients with type 2 diabetes mellitus and early diabetic nephropathy. Fetuin-A serum levels were assessed by ELISA in a cross-sectional setting in 153 patients with type 2 diabetes. Associations of fetuin-A with metabolic, inflammatory and vascular markers were studied. Atherosclerotic burden was assessed by ankle-brachial-index (ABI) as well as detection of common carotid artery intima-media thickness (IMT). Levels of fetuin-A were lower in male than in female patients (0.49 ± 0.15 vs. 0.56 ± 0.20 g/L, p = 0.02). In addition, there was an inverse correlation with age (r = -0.20, P = 0.01). Bivariate correlations adjusted for age and gender revealed no significant correlations with metabolic parameters, except for a weak inverse correlation with serum adiponectin (r = -0.19, p = 0.02). Regarding parameters of micro- and macrovascular disease, fetuin-A was significantly associated with ABI (r = 0.18, p = 0.04), while there was no association with IMT (r = -0.07, p = n.s). Patients with an ABI < 0.9 had lower fetuin A levels than patients with an ABI 0.9-1.3 or > 1.3 (0.43 ± 0.10 vs. 0.52 ± 0.17 vs. 0.54 ± 0.18 g/L p = 0.05). Neither GFR nor albuminuria were associated with fetuin-A serum levels. Patients with prevalent neuropathy did not have altered fetuin-A levels compared to diabetic controls. In step-wise logistic regression analysis including age, gender, HbA1c, total cholesterol, glomerular filtration rate and fetuin-A, only total cholesterol (β = 0.01, p = 0.02) and fetuin-A (β = -5.99, p = 0.03) proved to be independent predictors of an ABI < 0.9. The results of this cross-sectional study suggest that lower fetuin-A levels are associated with macrovascular late complications in high-risk type 2 diabetes patients while there are no associations of fetuin-A with metabolic status or microvascular complications." @default.
• W2123223887 created "2016-06-24" @default.
• W2123223887 creator A5009351391 @default.
• W2123223887 creator A5028813168 @default.
• W2123223887 creator A5033957516 @default.
• W2123223887 creator A5063830479 @default.
• W2123223887 creator A5064570153 @default.
• W2123223887 creator A5065997689 @default.
• W2123223887 creator A5067356779 @default.
• W2123223887 creator A5067599146 @default.
• W2123223887 creator A5070231919 @default.
• W2123223887 creator A5073473504 @default.
• W2123223887 date "2010-01-01" @default.
• W2123223887 modified "2023-10-16" @default.
• W2123223887 title "Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy" @default.
• W2123223887 cites W1968957121 @default.
• W2123223887 cites W1969316714 @default.
• W2123223887 cites W1972084938 @default.
• W2123223887 cites W1973948354 @default.
• W2123223887 cites W1998856961 @default.
• W2123223887 cites W1999445309 @default.
• W2123223887 cites W2000778877 @default.
• W2123223887 cites W2003752979 @default.
• W2123223887 cites W2035383914 @default.
• W2123223887 cites W2058579856 @default.
• W2123223887 cites W2058709767 @default.
• W2123223887 cites W2060405968 @default.
• W2123223887 cites W2066973446 @default.
• W2123223887 cites W2069030736 @default.
• W2123223887 cites W2073742622 @default.
• W2123223887 cites W2079174307 @default.
• W2123223887 cites W2089151518 @default.
• W2123223887 cites W2095408555 @default.
• W2123223887 cites W2102225039 @default.
• W2123223887 cites W2118958235 @default.
• W2123223887 cites W2130626015 @default.
• W2123223887 cites W2133281319 @default.
• W2123223887 cites W2138206839 @default.
• W2123223887 cites W2145251947 @default.
• W2123223887 cites W2146105386 @default.
• W2123223887 cites W2150369922 @default.
• W2123223887 cites W2151353276 @default.
• W2123223887 cites W2154497747 @default.
• W2123223887 cites W2157373537 @default.
• W2123223887 cites W2162474848 @default.
• W2123223887 cites W2164431067 @default.
• W2123223887 cites W2167455623 @default.
• W2123223887 doi "https://doi.org/10.1186/1475-2840-9-48" @default.
• W2123223887 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2949712" @default.
• W2123223887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20822519" @default.
• W2123223887 hasPublicationYear "2010" @default.
• W2123223887 type Work @default.
• W2123223887 sameAs 2123223887 @default.
• W2123223887 citedByCount "33" @default.
• W2123223887 countsByYear W21232238872012 @default.
• W2123223887 countsByYear W21232238872013 @default.
• W2123223887 countsByYear W21232238872014 @default.
• W2123223887 countsByYear W21232238872015 @default.
• W2123223887 countsByYear W21232238872017 @default.
• W2123223887 countsByYear W21232238872018 @default.
• W2123223887 countsByYear W21232238872019 @default.
• W2123223887 countsByYear W21232238872022 @default.
• W2123223887 countsByYear W21232238872023 @default.
• W2123223887 crossrefType "journal-article" @default.
• W2123223887 hasAuthorship W2123223887A5009351391 @default.
• W2123223887 hasAuthorship W2123223887A5028813168 @default.
• W2123223887 hasAuthorship W2123223887A5033957516 @default.
• W2123223887 hasAuthorship W2123223887A5063830479 @default.
• W2123223887 hasAuthorship W2123223887A5064570153 @default.
• W2123223887 hasAuthorship W2123223887A5065997689 @default.
• W2123223887 hasAuthorship W2123223887A5067356779 @default.
• W2123223887 hasAuthorship W2123223887A5067599146 @default.
• W2123223887 hasAuthorship W2123223887A5070231919 @default.
• W2123223887 hasAuthorship W2123223887A5073473504 @default.
• W2123223887 hasBestOaLocation W21232238871 @default.
• W2123223887 hasConcept C108625454 @default.
• W2123223887 hasConcept C126322002 @default.
• W2123223887 hasConcept C134018914 @default.
• W2123223887 hasConcept C153911025 @default.
• W2123223887 hasConcept C164705383 @default.
• W2123223887 hasConcept C2776174234 @default.
• W2123223887 hasConcept C2776782570 @default.
• W2123223887 hasConcept C2777180221 @default.
• W2123223887 hasConcept C2777391703 @default.
• W2123223887 hasConcept C2778541144 @default.
• W2123223887 hasConcept C2778653478 @default.
• W2123223887 hasConcept C2779339615 @default.
• W2123223887 hasConcept C2779922275 @default.
• W2123223887 hasConcept C2781184683 @default.
• W2123223887 hasConcept C2908647359 @default.
• W2123223887 hasConcept C2910068830 @default.
• W2123223887 hasConcept C2987047532 @default.
• W2123223887 hasConcept C555175668 @default.
• W2123223887 hasConcept C555293320 @default.
• W2123223887 hasConcept C71924100 @default.
• W2123223887 hasConcept C86803240 @default.
• W2123223887 hasConcept C90924648 @default.
• W2123223887 hasConcept C99454951 @default.

• next